miR-17-92 fine-tunes MYC expression and function to ensure optimal B cell lymphoma growth
Marija Mihailovich(Human Technopole), Tiziana Bonaldi(University of Milan), Daniele Musiani(European Institute of Oncology), Francesco M. Mancuso(Cancer Genomics Centre), Stefano Casola(IFOM), David A. Cairns(BMW (Germany)), Federico Zambelli(University of Milan), Gabriele Varano(IFOM), Giulio Pavesi(University of Milan), Michael Bremang(European Institute of Oncology), Elena Vitale(European Institute of Oncology), Valeria Spadotto(European Institute of Oncology)
Cited by 107
Related Papers
Regulation of the Germinal Center Response by MicroRNA-155
|Science|2007|1.5k
Transcription factor IRF4 controls plasma cell differentiation and class-switch recombination
|Nature Immunology|2006|771
Mutational Spectrum, Copy Number Changes, and Outcome: Results of a Sequencing Study of Patients With Newly Diagnosed Myeloma
|Journal of Clinical Oncology|2015|564
B cell receptor signal strength determines B cell fate
|Nature Immunology|2004|556